Related Experiment Videos
Immunosuppressive properties of calcium channel blockers
K K Chitwood1, K L Heim-Duthoy
1Drug Evaluation Unit, Hennepin County Medical Center Pharmacy, University of Minnesota, Minneapolis, MN 55404.
Insights
Calcium channel blockers show potential as immunosuppressants for transplant patients, offering benefits beyond cardiovascular effects. These calcium antagonists may improve transplant outcomes by modulating immune responses, independent of their cardiac actions.
Area of Science:
- Immunology
- Pharmacology
- Transplantation
Background:
- Solid organ transplant recipients frequently experience cardiovascular disease.
- Calcium channel blockers are commonly prescribed for cardiovascular conditions in this population.
- Emerging research suggests non-cardiovascular benefits of calcium antagonists.
Purpose of the Study:
- To investigate the potential immunosuppressive properties of calcium channel blockers.
- To explore the effects of calcium antagonists on both arms of the immune system.
- To assess the utility of these agents in solid organ transplant recipients.
Main Methods:
- In vitro studies examining cellular immune responses.
- In vivo studies evaluating effects on immune modulation.
- Analysis of actions on afferent and efferent immune pathways.
Main Results:
- Calcium channel blockers demonstrated immunosuppressive properties in vitro and in vivo.
- These agents affect cellular mechanisms in both arms of the immune system.
- Potential benefits observed when used alone or with cyclosporine.
Conclusions:
- Calcium channel blockers possess immunosuppressive properties relevant to transplantation.
- These properties may offer benefits to solid organ transplant recipients beyond cardiovascular effects.
- Further research into calcium antagonists as immunosuppressive agents is warranted for transplant populations.
Abstract:
Calcium channel blockers are extensively used for their beneficial effects on the cardiovascular system. Solid organ transplant recipients commonly have cardiovascular disease and are often treated with these agents. Research demonstrates that calcium antagonists may have beneficial effects in this population that are independent of their effects on the cardiovascular system. Indeed, both in vitro and in vivo studies suggested that they may possess immunosuppressive properties. Their actions at the cellular level in both the afferent and efferent arms of the immune system indicate that alone, as well as in combination with cyclosporine, these agents possess immunosuppressive properties that may potentially benefit the transplant population.